Literature DB >> 15921395

The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.

José-Tomás Navarro, Natàlia Lloveras, Josep-Maria Ribera, Albert Oriol, José-Luis Mate, Evarist Feliu.   

Abstract

In the era of highly active antiretroviral treatment (HAART), the prognosis of AIDS-related lymphomas might be similar to that of aggressive B-cell lymphomas in human immunodeficiency (HIV)-negative patients. In this study we found that HIV-infected patients with diffuse large B-cell lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone (CHOP) and HAART showed a similar response rate to chemotherapy, disease-free survival and overall survival as those of HIV-negative patients receiving CHOP.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15921395

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  18 in total

1.  Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.

Authors:  Ulas Darda Bayraktar; Luis A Diaz; Brittany Ashlock; Ngoc Toomey; Lisa Cabral; Soley Bayraktar; Denise Pereira; Dirk P Dittmer; Juan Carlos Ramos
Journal:  Leuk Lymphoma       Date:  2013-08-28

Review 2.  Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Authors:  Stefan K Barta; Xiaonan Xue; Dan Wang; Roni Tamari; Jeannette Y Lee; Nicolas Mounier; Lawrence D Kaplan; Josep-Maria Ribera; Michele Spina; Umberto Tirelli; Rudolf Weiss; Lionel Galicier; Francois Boue; Wyndham H Wilson; Christoph Wyen; Albert Oriol; José-Tomás Navarro; Kieron Dunleavy; Richard F Little; Lee Ratner; Olga Garcia; Mireia Morgades; Scot C Remick; Ariela Noy; Joseph A Sparano
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

3.  Right upper quadrant pain and mass in a 41-year-old previously healthy man: a presenting feature of HIV-associated extranodal diffuse large B cell lymphoma with cardiac involvement.

Authors:  Abhirami Vivekanandarajah; Vijaya Raj Bhatt; Balakumar Krishnarasa; Srujitha Murukutla; Arnold Brenner; Shilpi Gupta
Journal:  BMJ Case Rep       Date:  2012-04-28

4.  Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South Africa.

Authors:  Pieter de Witt; Deborah J Maartens; Thomas S Uldrick; Gerhard Sissolak
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

5.  Mature outcomes and prognostic indices in diffuse large B-cell lymphoma in Malawi: a prospective cohort.

Authors:  Matthew S Painschab; Edwards Kasonkanji; Takondwa Zuze; Bongani Kaimila; Tamiwe Tomoka; Richard Nyasosela; Ruth Nyirenda; Bal M Dhungel; Maurice Mulenga; Maria Chikasema; Blessings Tewete; Asekanadziwa Mtangwanika; Sarah Chiyoyola; Wilberforce Mhango; Fred Chimzimu; Coxcilly Kampani; Robert Krysiak; Thomas C Shea; Nathan D Montgomery; Yuri Fedoriw; Satish Gopal
Journal:  Br J Haematol       Date:  2018-11-18       Impact factor: 6.998

Review 6.  Lung Malignancies in HIV Infection.

Authors:  Keith Sigel; Robert Pitts; Kristina Crothers
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

7.  HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

Authors:  Silvia Montoto; Kate Shaw; Jessica Okosun; Shreyans Gandhi; Paul Fields; Andrew Wilson; Milensu Shanyinde; Kate Cwynarski; Robert Marcus; Johannes de Vos; Anna Marie Young; Melinda Tenant-Flowers; Chloe Orkin; Margaret Johnson; Daniella Chilton; John G Gribben; Mark Bower
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

8.  Central nervous system involvement in AIDS-related lymphomas.

Authors:  Stefan K Barta; Jitesh Joshi; Nicolas Mounier; Xiaonan Xue; Dan Wang; Josep-Maria Ribera; Jose-Tomas Navarro; Christian Hoffmann; Kieron Dunleavy; Richard F Little; Wyndham H Wilson; Michele Spina; Lionel Galicier; Ariela Noy; Joseph A Sparano
Journal:  Br J Haematol       Date:  2016-04-07       Impact factor: 6.998

9.  Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy.

Authors:  José-Tomás Navarro; Josep-Maria Ribera; Albert Oriol; Blanca Xicoy; José-Luis Mate; Guillem Sirera; Natalia Lloveras; Fuensanta Millá; Evarist Feliu
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

10.  HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.

Authors:  Juan Pablo Alderuccio; Adam J Olszewski; Andrew M Evens; Graham P Collins; Alexey V Danilov; Mark Bower; Deepa Jagadeesh; Catherine Zhu; Amy Sperling; Seo-Hyun Kim; Ryan Vaca; Catherine Wei; Suchitra Sundaram; Nishitha Reddy; Alessia Dalla Pria; Christopher D'Angelo; Umar Farooq; David A Bond; Stephanie Berg; Michael C Churnetski; Amandeep Godara; Nadia Khan; Yun Kyong Choi; Shireen Kassam; Maryam Yazdy; Emma Rabinovich; Frank A Post; Gaurav Varma; Reem Karmali; Madelyn Burkart; Peter Martin; Albert Ren; Ayushi Chauhan; Catherine Diefenbach; Allandria Straker-Edwards; Andreas Klein; Kristie A Blum; Kirsten Marie Boughan; Agrima Mian; Bradley M Haverkos; Victor M Orellana-Noia; Vaishalee P Kenkre; Adam Zayac; Seth M Maliske; Narendranath Epperla; Paolo Caimi; Scott E Smith; Manali Kamdar; Parameswaran Venugopal; Tatyana A Feldman; Daniel Rector; Stephen D Smith; Andrzej Stadnik; Craig A Portell; Yong Lin; Seema Naik; Silvia Montoto; Izidore S Lossos; Kate Cwynarski
Journal:  Blood Adv       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.